AMYLIN PHARMACEUTICALS INC·4

Mar 7, 6:05 PM ET

Mihalik Vincent P 4

4 · AMYLIN PHARMACEUTICALS INC · Filed Mar 7, 2012

Insider Transaction Report

Form 4
Period: 2012-03-06
Mihalik Vincent P
SVP Sales and Marketing, CCO
Transactions
  • Award

    Common Stock

    2012-03-06+10,00039,027 total
  • Award

    Common Stock

    2012-03-06+1,529.34,519.4 total(indirect: by ESOP)
  • Award

    Incentive Stock Option (right to buy)

    2012-03-06+7,0217,021 total
    Exercise: $16.02Exp: 2019-03-06Common Stock (7,021 underlying)
  • Award

    Non-Qualified Stock Option (right to buy)

    2012-03-06+42,97942,979 total
    Exercise: $16.02Exp: 2019-03-06Common Stock (42,979 underlying)
Holdings
  • Common Stock

    (indirect: By 401(k))
    1,338.2
Footnotes (3)
  • [F1]Represents a restricted stock unit award that vests in three equal annual installments from the date of grant. Restricted stock units are generally settled in shares of common stock of the company on the vesting date.
  • [F2]These shares fully vest four years from the date of the reporting person's participation in the ESOP in four equal annual installments and are generally distributed upon termination of employment.
  • [F3]25% of shares vest one year from the date of grant and the remainder vest in three equal annual installments becoming fully vested four years from the date of grant.

Documents

1 file
  • 4
    edgardoc.xmlPrimary

    PRIMARY DOCUMENT